Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.

Mchugh, Dm; Cameron, Ca; Abdenur, Je; Abdulrahman, M; Adair, O; Al Nuaimi SA,; Åhlman, H; Allen, Jj; Antonozzi, I; Archer, S; S, Au; Auray Blais, C; Baker, M; Bamforth, F; Beckmann, K; Pino, Gb; Berberich, Sl; Binard, R; Boemer, F; Bonham, J; Breen, Nn; Bryant, Sc; Caggana, M; Caldwell, Sg; Camilot, M; Campbell, C; Carducci, C; Bryant, Sc; Caggana, M; Caldwell, Sg; Camilot, M; Campbell, C; Carducci, C; Cariappa, R; Carlisle, C; Caruso, U; Cassanello, M; Castilla, Am; Ramos, De; Chakraborty, P; Chandrasekar, R; Ramos, Ac; Cheillan, D; Chien, Yh; Childs, Ta; Chrastina, P; Sica, Yc; de Juan JA,; Colandre, Me; Espinoza, Vc; Corso, G; Currier, R; Cyr, D; Czuczy, N; D'Apolito, O; Davis, T; de Sain Van der Velden MG,; Delgado Pecellin, C; Di Gangi IM,; Di Stefano CM,; Dotsikas, Y; Downing, M; Downs, Sm; B, Dy; Dymerski, M; Rueda, I; Elvers, B; Eaton, R; Eckerd, Bm; El Mougy, F; Eroh, S; Espada, M; Evans, C; Fawbush, S; Fijolek, Kf; Fisher, L; Franzson, L; Frazier, Dm; Garcia, Lr; Bermejo, Ms; Gavrilov, D; Gerace, R; Giordano, G; Irazabal, Yg; Greed, Lc; Grier, R; Grycki, E; X, Gu; Gulamali Majid, F; Hagar, Af; Han, L; Hannon, Wh; Haslip, C; Hassan, Fa; M, He; Hietala, A; Himstedt, L; Hoffman, Gl; Hoffman, W; Hoggatt, P; Hopkins, Pv; Hougaard, Dm; Hughes, K; Hunt, Pr; Hwu, Wl; Hynes, J; Ibarra González, I; Ingham, Ca; Ivanova, M; Jacox, Wb; John, C; Johnson, Jp; Jónsson, Jj; Karg, E; Kasper, D; Klopper, B; Katakouzinos, D; Khneisser, I; Knoll, D; Kobayashi, H; Koneski, R; Kozich, V; Kouapei, R; Kohlmueller, D; Kremensky, I; LA MARCA, Giancarlo; Lavochkin, M; Lee, Sy; Lehotay, Dc; Lemes, A; Lepage, J; Lesko, B; Lewis, B; Lim, C; Linard, S; Lindner, M; Lloyd Puryear MA,; Lorey, F; Loukas, Yl; Luedtke, J; Maffitt, N; Magee, Jf; Manning, A; Manos, S; Marie, S; Hadachi, Sm; Marquardt, G; Martin, Sj; Matern, D; Mayfield Gibson SK,; Mayne, P; Mccallister, Td; Mccann, M; Mcclure, J; Mcgill, Jj; Mckeever, Cd; Mcneilly, B; Morrissey, Ma; Moutsatsou, P; Mulcahy, Ea; Nikoloudis, D; Norgaard Pedersen, B; Oglesbee, D; Oltarzewski, M; Ombrone, D; Ojodu, J; Papakonstantinou, V; Reoyo, Sp; Park, Hd; Pasquali, M; Pasquini, E; Patel, P; Pass, Ka; Peterson, C; Pettersen, Rd; Pitt, Jj; Poh, S; Pollak, A; Porter, C; Poston, Pa; Price, Rw; Queijo, C; Quesada, J; Randell, E; Ranieri, E; Raymond, K; Reddic, Je; Reuben, A; Ricciardi, C; Rinaldo, P; Rivera, Jd; Roberts, A; Rocha, H; Roche, G; Greenberg, Cr; Mellado, Jm; Juan Fita MJ,; Ruiz, C; Ruoppolo, M; Rutledge, Sl; Ryu, E; Saban, C; Sahai, I; García Blanco MI,; Santiago Borrero, P; Schenone, A; Schoos, R; Schweitzer, B; Scott, P; Seashore, Mr; Seeterlin, Ma; Sesser, De; Sevier, Dw; Shone, Sm; Sinclair, G; Skrinska, Va; Stanley, El; Strovel, Et; Jones, Al; Sunny, S; Takats, Z; Tanyalcin, T; Teofoli, F; Thompson, Jr; Tomashitis, K; Domingos, Mt; Torres, J; Torres, R; Tortorelli, S; Turi, S; Turner, K; Tzanakos, N; Valiente, Ag; Vallance, H; Vela Amieva, M; Vilarinho, L; von Döbeln, U; Vincent, Mf; Vorster, Bc; Watson, Ms; Webster, D; Weiss, S; Wilcken, B; Wiley, V; Williams, Sk; Willis, Sa; Woontner, M; Wright, K; Yahyaoui, R; Yamaguchi, S; Yssel, M; Zakowicz, W. M.

Purpose: To achieve clinical validation of cutoff values for newborn screening by tandem mass spectrometry through a worldwide collaborative effort. Methods: Cumulative percentiles of amino acids and acylcarnitines in dried blood spots of approximately 25–30 million normal newborns and 10,742 deidentified true positive cases are compared to assign clinical significance, which is achieved when the median of a disorder range is, and usually markedly outside, either the 99th or the 1st percentile of the normal population. The cutoff target ranges of analytes and ratios are then defined as the interval between selected percentiles of the two populations. When overlaps occur, adjustments are made to maximize sensitivity and specificity taking all available factors into consideration. Results: As of December 1, 2010, 130 sites in 45 countries have uploaded a total of 25,114 percentile data points, 565,232 analyte results of true positive cases with 64 conditions, and 5,341 cutoff values. The average rate of submission of true positive cases between December 1, 2008, and December 1, 2010, was 5.1 cases/day. This cumulative evidence generated 91 high and 23 low cutoff target ranges. The overall proportion of cutoff values within the respective target range was 42% (2,269/5,341). Conclusion: An unprecedented level of cooperation and collaboration has allowed the objective definition of cutoff target ranges for 114 markers to be applied to newborn screening of rare metabolic disorders.

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project / McHugh DM; Cameron CA; Abdenur JE; Abdulrahman M; Adair O; Al Nuaimi SA; Åhlman H; Allen JJ; Antonozzi I; Archer S; Au S; Auray-Blais C; Baker M; Bamforth F; Beckmann K; Pino GB; Berberich SL; Binard R; Boemer F; Bonham J; Breen NN; Bryant SC; Caggana M; Caldwell SG; Camilot M; Campbell C; Carducci C; Bryant SC; Caggana M; Caldwell SG; Camilot M; Campbell C; Carducci C; Cariappa R; Carlisle C; Caruso U; Cassanello M; Castilla AM; Ramos DE; Chakraborty P; Chandrasekar R; Ramos AC; Cheillan D; Chien YH; Childs TA; Chrastina P; Sica YC; de Juan JA; Colandre ME; Espinoza VC; Corso G; Currier R; Cyr D; Czuczy N; D'Apolito O; Davis T; de Sain-Van der Velden MG; Delgado Pecellin C; Di Gangi IM; Di Stefano CM; Dotsikas Y; Downing M; Downs SM; Dy B; Dymerski M; Rueda I; Elvers B; Eaton R; Eckerd BM; El Mougy F; Eroh S; Espada M; Evans C; Fawbush S; Fijolek KF; Fisher L; Franzson L; Frazier DM; Garcia LR; Bermejo MS; Gavrilov D; Gerace R; Giordano G; Irazabal YG; Greed LC; Grier R; Grycki E; Gu X; Gulamali-Majid F; Hagar AF; Han L; Hannon WH; Haslip C; Hassan FA; He M; Hietala A; Himstedt L; Hoffman GL; Hoffman W; Hoggatt P; Hopkins PV; Hougaard DM; Hughes K; Hunt PR; Hwu WL; Hynes J; Ibarra-González I; Ingham CA; Ivanova M; Jacox WB; John C; Johnson JP; Jónsson JJ; Karg E; Kasper D; Klopper B; Katakouzinos D; Khneisser I; Knoll D; Kobayashi H; Koneski R; Kozich V; Kouapei R; Kohlmueller D; Kremensky I; la Marca G; Lavochkin M; Lee SY; Lehotay DC; Lemes A; Lepage J; Lesko B; Lewis B; Lim C; Linard S; Lindner M; Lloyd-Puryear MA; Lorey F; Loukas YL; Luedtke J; Maffitt N; Magee JF; Manning A; Manos S; Marie S; Hadachi SM; Marquardt G; Martin SJ; Matern D; Mayfield Gibson SK; Mayne P; McCallister TD; McCann M; McClure J; McGill JJ; McKeever CD; McNeilly B; Morrissey MA; Moutsatsou P; Mulcahy EA; Nikoloudis D; Norgaard-Pedersen B; Oglesbee D; Oltarzewski M; Ombrone D; Ojodu J; Papakonstantinou V; Reoyo SP; Park HD; Pasquali M; Pasquini E; Patel P; Pass KA; Peterson C; Pettersen RD; Pitt JJ; Poh S; Pollak A; Porter C; Poston PA; Price RW; Queijo C; Quesada J; Randell E; Ranieri E; Raymond K; Reddic JE; Reuben A; Ricciardi C; Rinaldo P; Rivera JD; Roberts A; Rocha H; Roche G; Greenberg CR; Mellado JM; Juan-Fita MJ; Ruiz C; Ruoppolo M; Rutledge SL; Ryu E; Saban C; Sahai I; García-Blanco MI; Santiago-Borrero P; Schenone A; Schoos R; Schweitzer B; Scott P; Seashore MR; Seeterlin MA; Sesser DE; Sevier DW; Shone SM; Sinclair G; Skrinska VA; Stanley EL; Strovel ET; Jones AL; Sunny S; Takats Z; Tanyalcin T; Teofoli F; Thompson JR; Tomashitis K; Domingos MT; Torres J; Torres R; Tortorelli S; Turi S; Turner K; Tzanakos N; Valiente AG; Vallance H; Vela-Amieva M; Vilarinho L; von Döbeln U; Vincent MF; Vorster BC; Watson MS; Webster D; Weiss S; Wilcken B; Wiley V; Williams SK; Willis SA; Woontner M; Wright K; Yahyaoui R; Yamaguchi S; Yssel M; Zakowicz WM.. - In: GENETICS IN MEDICINE. - ISSN 1098-3600. - ELETTRONICO. - 13:(2011), pp. 230-254.